[1] SEALAND R,RAZAVI C,ADLER R A. Diabetes mellitus and osteoporosis [J]. Curr Diab Rep,2013,13(3):411-418.
[2] KURRA S,FINK D A,SIRIS E S. Osteoporosis-associated fracture and diabetes[J]. Endocrinol Metab Clin North Am,2014,43(1):233-243.
[3] YAMAMOTO M,SUGIMOTO T. Advanced glycation end products,diabetes,and bone strength[J]. Curr Osteoporos Rep,2016,14(6): 320-326.
[4] ANTONOPOULOU M,BAHTIYAR G,BANERJI M A,et al. Diabetes and bone health[J]. Maturitas,2013,76(3):253-259.
[5] MASCITELLI L,PEZZETTA F. Diabetes and osteoporotic fractures[J]. CMAJ,2007,177(11):1391-1392.
[6] MOSER M,BINDER O,WU Y,et al. BMPER,a novel endothelial cell precursor-derived protein,antagonizes bone morphogenetic protein signaling and endothelial cell differentiation[J]. Mol Cell Biol,2003,23(16):5664-5679.
[7] IKEYA M,KAWADA M,KIYONARI H,et al. Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis[J].Development,2006,133(22):4463-4473.
[8] BEN-NERIAH Z,MICHAELSON-COHEN R,INBAR-FEIGENBERG M,et al. A deleterious founder mutation in the BMPER gene causes diaphanospondylodysostosis(DSD)[J]. Am J Med Genet A,2011,155A(11):2801-2806.
[9] KUCHINSKAYA E,GRIGELIONIENE G,HAMMARSJ?魻 A,et al. Extending the phenotype of BMPER-related skeletal dysplasias to ischiospinal dysostosis[J]. Orphanet J Rare Dis,2016,11: 1.
[10] ENSRUD K E,CRANDALL C J. Osteoporosis[J]. Ann Intern Med,2017,167(3): Itc17-Itc32.
[11] FU C,ZHANG X,YE F,et al. High insulin levels in KK-Ay diabetic mice cause increased cortical bone mass and impaired trabecular micro-structure[J].Int J Mol Sci,2015,16(4):8213-8226.
[12] CHIODINI I,CATALANO A,GENNARI L,et al. Osteoporosis and fragility fractures in type 2 Diabetes[J]. J Diabetes Res,2020,2020: 9342696.
[13] CORTET B,LUCAS S,LEGROUX-GEROT I,et al. Bone disorders associated with diabetes mellitus and its treatments[J].Joint Bone Spine,2019,86(3):315-320.
[14] MOHSIN S,BANIYAS M M,ALDARMAKI R S,et al. An update on therapies for the treatment of diabetes-induced osteoporosis[J]. Expert Opin Biol Ther,2019,19(9):937-948.
[15] ZHANG Y,YANG J H. Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts[J]. J Cell Biochem,2013,114(11):2595-2602.
[16] FENG Z,DENG H,DU J,et al. Lentiviral-mediated RNAi targeting p38MAPK ameliorates high glucose-induced apoptosis in osteoblast MC3T3-E1 cell line[J].Indian J Exp Biol,2011,49(2):94-104.
[17] MAO H,LI L,FAN Q,et al. Loss of bone morphogenetic protein-binding endothelial regulator causes insulin resistance[J].Nat Commun,2021,12(1): 1927.
[18] LANE J M,RUSSELL L,KHAN S N. Osteoporosis[J]. Clin Orthop Relat Res,2000,(372):139-150.
[19] TERAO Y,SATOMI-KOBAYASHI S,HIRATA K,et al. Involvement of Rho-associated protein kinase (ROCK) and bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) in high glucose-increased alkaline phosphatase expression and activity in human coronary artery smooth muscle cells[J]. Cardiovasc Diabetol,2015,14:104.
[20] SATOMI-KOBAYASHI S,KINUGASA M,KOBAYASHI R,et al. Osteoblast-like differentiation of cultured human coronary artery smooth muscle cells by bone morphogenetic protein endothelial cell precursor-derived regulator (BMPER)[J]. J Biol Chem,2012,287(36):30336-30345.
[21] HUANG P,YAN R,ZHANG X,et al. Activating Wnt/β-catenin signaling pathway for disease therapy:challenges and opportunities[J]. Pharmacol Ther,2019,196:79-90.
[22] JIANG T,XIA C,CHEN X,et al. Melatonin promotes the BMP9-induced osteogenic differentiation of mesenchymal stem cells by activating the AMPK/β-catenin signalling pathway[J]. Stem Cell Res Ther,2019,10(1):408.
[23] JACKULIAK P,PAYER J. Osteoporosis,fractures,and diabetes[J]. Int J Endocrinol,2014,2014:820615.
[24] XIA K,CEN X,YU L,et al.Long noncoding RNA expression profiles during the NEL-like 1 protein-induced osteogenic differentiation[J]. J Cell Physiol,2020,235(9):6010-6022.
[25] YU A X,XU M L,YAO P,et al.Corylin,a flavonoid derived from Psoralea Fructus,induces osteoblastic differentiation via estrogen and Wnt/β-catenin signaling pathways[J]. FASEB J,2020,34(3):4311-4328.